Lineage Cell Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	40.79	45.79	35.44	11.36	55.74
Short-Term Investments	14.99	2.02	0.05	46.52	2.62
Cash & Short-Term Investments	55.78	47.81	35.49	57.88	58.36
Cash Growth	16.68%	34.69%	-38.67%	-0.83%	40.41%
Accounts Receivable	0.89	0.64	0.75	0.3	50.84
Other Current Assets	2.49	2.55	2.2	1.83	2.35
Total Current Assets	59.16	51	38.44	60	111.55
Net Property, Plant & Equipment	4.7	4.4	4.77	5.67	4.87
Other Intangible Assets	31.7	46.54	46.56	46.69	46.82
Goodwill	10.67	10.67	10.67	10.67	10.67
Other Long-Term Assets	6.36	0.61	0.58	0.63	0.63
Total Assets	112.58	113.22	101.02	123.66	174.55
Accounts Payable	7.18	5.44	6.27	8.61	27.97
Current Portion of Leases	0.85	1.15	0.88	0.95	0.83
Unearned Revenue	3.33	7.39	10.81	9.42	18.12
Other Current Liabilities	-	-	-	-	0.2
Total Current Liabilities	11.37	13.98	17.96	18.98	47.12
Long-Term Leases	1.57	1.36	2.07	2.94	1.97
Other Long-Term Liabilities	56.31	20.87	18.97	29.8	34.56
Total Long-Term Liabilities	57.87	22.23	21.04	32.75	36.53
Total Liabilities	69.24	36.21	39	51.73	83.65
Common Stock	515.47	484.72	451.34	440.28	434.53
Accumulated Other Comprehensive Income	-3.92	-2.88	-3.07	-3.57	-5.21
Retained Earnings	-467	-403.47	-384.86	-363.37	-337.1
Total Common Shareholders' Equity	44.55	78.38	63.42	73.34	92.22
Minority Interest	-1.2	-1.37	-1.4	-1.4	-1.32
Shareholders' Equity	43.35	77.01	62.02	71.94	90.9
Total Liabilities & Equity	112.58	113.22	101.02	123.66	174.55
Total Debt	2.42	2.51	2.95	3.9	2.8
Net Cash (Debt)	53.36	45.29	32.54	53.98	55.56
Net Cash Growth	17.82%	39.19%	-39.72%	-2.84%	45.21%
Net Cash Per Share	0.23	0.23	0.19	0.32	0.34
Book Value	44.55	78.38	63.42	73.34	92.22
Book Value Per Share	0.19	0.39	0.37	0.43	0.56
Tangible Book Value	2.18	21.17	6.19	15.98	34.73
Tangible Book Value Per Share	0.01	0.11	0.04	0.09	0.21

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q